Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet
NCT03495206
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Stroke, Acute
Intracranial Hemorrhages
Interventions
DRUG:
Y-2(Edaravone And Borneol) Sublingual Tablet
Sponsor
Yantai YenePharma Co., Ltd.